Oxford suspended trial Provisional COVID-19 vaccine after volunteers are unaware
The final clinical trial worldwide for the coronavirus vaccine developed by the pharmaceutical giant. "Astra Seneca" (AstraZeneca) and the University of Oxford Was suspended after a volunteer in the UK had an idiopathic illness.
Astra Seneca's statement said Suspension of vaccine trials to validate such safety data is normal. Anytime an unexplained illness arose over a period of time in the trial. While monitoring ensures that the developer maintains the integrity of the experiment. By in the big experiment Illness can happen by chance. However, it needs to be independently reviewed for careful examination.
While the BBC news agency reported that This is the second time that Oxford vaccine trials have to be suspended. Such events are common in large-scale trials. When an accident occurs, the volunteer is hospitalized without a clear cause of the illness. The trial must be suspended immediately. The vaccine trial is expected to resume very soon.
The Astrazeneca Corona Virus Vaccine is called "Oxford vaccine" because it was developed in conjunction with the University of Oxford of the United Kingdom. And the results of close trials from around the world were watched as one of the vaccines against COVID-19. The first to enter the market after successful phase 1 and 2 trials and entered Phase 3 trials a few weeks ago. There are 30,000 volunteers in the US, UK, Brazil and South Africa. The report said phase 3 vaccine trials typically involve thousands of participants and could take years.
President Donald Trump previously said he wanted the vaccine to be readily available in the United States. Ahead of the Nov. 3, 2020 presidential election, Trump's comments raised concerns that vaccines could be accelerated with a focus on politics over safety.
Continue to follow : slotxo
